Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Apr;63(4):550-2.
doi: 10.1038/bjc.1991.129.

Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot study

Affiliations
Free PMC article

Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot study

M S Heier et al. Br J Cancer. 1991 Apr.
Free PMC article

Abstract

The pathophysiology of Raynaud's phenomenon after Cisplatin-Bleomycin-Vinblastine combination chemotherapy, its relationship to polyneuropathy, and response to transcutaneous nerve stimulation (TNS), was studied in eight patients previously treated for testicular cancer. Peripheral circulation in the index finger was measured by laser Doppler flowmetry before and after cold provocation. In all patients there was an exaggerated and prolonged vasoconstrictor response to cold, with a mean flux reduction of 61%, and a mean restitution time of greater than 7 min, characteristic of Raynaud's phenomenon of the vasospastic type. The normal controls had a mean flux reduction of 24% and a restitution time of 1.5 min. Clinical examination and nerve conduction measurements revealed a mild polyneuropathy in five of the eight patients, but an etiological relationship with Raynaud's phenomenon could not be ascertained. There was no measurable effect of TNS.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Oncol. 1989 Jul;7(7):940-2 - PubMed
    1. Brain. 1973;96(1):69-86 - PubMed
    1. Cancer. 1985 Dec 15;56(12):2765-70 - PubMed
    1. Br J Cancer. 1990 Jan;61(1):151-5 - PubMed
    1. Gen Pharmacol. 1984;15(2):107-13 - PubMed

MeSH terms